1. Home
  2. KMDA vs DH Comparison

KMDA vs DH Comparison

Compare KMDA & DH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • DH
  • Stock Information
  • Founded
  • KMDA 1990
  • DH 2011
  • Country
  • KMDA Israel
  • DH United States
  • Employees
  • KMDA N/A
  • DH 782
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • DH Computer Software: Prepackaged Software
  • Sector
  • KMDA Health Care
  • DH Technology
  • Exchange
  • KMDA Nasdaq
  • DH Nasdaq
  • Market Cap
  • KMDA 392.2M
  • DH 332.0M
  • IPO Year
  • KMDA N/A
  • DH 2021
  • Fundamental
  • Price
  • KMDA $6.84
  • DH $3.23
  • Analyst Decision
  • KMDA Strong Buy
  • DH Hold
  • Analyst Count
  • KMDA 2
  • DH 5
  • Target Price
  • KMDA $13.00
  • DH $4.35
  • AVG Volume (30 Days)
  • KMDA 56.5K
  • DH 342.8K
  • Earning Date
  • KMDA 11-12-2025
  • DH 11-06-2025
  • Dividend Yield
  • KMDA 2.92%
  • DH N/A
  • EPS Growth
  • KMDA 27.97
  • DH N/A
  • EPS
  • KMDA 0.32
  • DH N/A
  • Revenue
  • KMDA $169,517,000.00
  • DH $244,926,000.00
  • Revenue This Year
  • KMDA $14.49
  • DH N/A
  • Revenue Next Year
  • KMDA $10.12
  • DH $0.68
  • P/E Ratio
  • KMDA $20.74
  • DH N/A
  • Revenue Growth
  • KMDA 9.67
  • DH N/A
  • 52 Week Low
  • KMDA $5.18
  • DH $2.15
  • 52 Week High
  • KMDA $9.16
  • DH $5.68
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 41.12
  • DH 30.84
  • Support Level
  • KMDA $6.50
  • DH $3.17
  • Resistance Level
  • KMDA $6.89
  • DH $4.06
  • Average True Range (ATR)
  • KMDA 0.13
  • DH 0.21
  • MACD
  • KMDA -0.01
  • DH -0.10
  • Stochastic Oscillator
  • KMDA 38.50
  • DH 1.69

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: